Thyroid 2007;17:763-5
Based on these two trials, DESTINY-Lung01 and DESTINY-Lung02, T-DXd 5.4 mg/kg was approved by the FDA and the European Medicines Agency (EMA) for patients with previously treated HER2 -mutant metastatic NSCLC marking the first approval of an ADC for lung cancer
Diabetes 2005, 54:146-151, Bose AK, Mocanu MM, Carr RD, Yellon DM: Glucagon like peptide-1 is protective against myocardial ischemia/ reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model
Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL 3rd, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS
We hypothesized that prolonged L-carnitine supplementation in very preterm infants would improve weight gain and shorten length of stay in the hospital